Sign in

You're signed outSign in or to get full access.

Candace Matthews

Chair of the Board at APTARGROUPAPTARGROUP
Board

About Candace Matthews

Candace Matthews, age 66, is the independent Chair of Aptar’s Board since May 2023 and has served as an independent director since 2021. She is a seasoned consumer and beauty products executive, including roles at Amway (Chief Reputation Officer 2020–2021; Regional President, Americas; Chief Marketing Officer starting 2007), L’Oréal USA (President, SoftSheen-Carson), The Coca-Cola Company, CIBA Vision, Bausch + Lomb, Procter & Gamble, and General Mills, bringing strategic planning, governance, finance, and senior management experience to Aptar’s board . She is currently a member of Aptar’s Corporate Governance Committee and is designated independent under NYSE standards .

Past Roles

OrganizationRoleTenureCommittees/Impact
Amway Corp.Chief Reputation OfficerJun 2020 – Jun 2021Oversaw global reputation strategy and CSR
Amway Corp.Regional President, AmericasSix years (pre-2020)Led all operations across North, Central, South America
Amway Corp.Chief Marketing OfficerStarting 2007Senior marketing leadership
L’Oréal USA (SoftSheen-Carson)President, Consumer Products DivisionNot disclosedBeauty products leadership
The Coca-Cola CompanyLeadership roleNot disclosedConsumer brand experience
CIBA Vision CorporationInnovation roleNot disclosedProduct innovation exposure
Bausch + Lomb; Procter & Gamble; General MillsVarious rolesNot disclosedConsumer goods experience

External Roles

OrganizationRoleTenurePublic/PrivateCommittee Roles
Société BIC S.A.DirectorCurrentPublicNot disclosed
Corewell Health Foundation (formerly Spectrum Health Foundation)DirectorCurrentNon-profitNot disclosed
MillerKnoll, Inc. (formerly Herman Miller, Inc.)DirectorFormerPublicNot disclosed
Popeye’s Louisiana Kitchen Inc.DirectorFormerPublicNot disclosed

Board Governance

  • Roles: Non-executive Chair since May 2023; Corporate Governance Committee member .
  • Independence: Aptar reports 9 of 10 current directors are independent; Matthews is classified independent under NYSE standards .
  • Executive sessions: Independent directors meet in executive session at each scheduled meeting; the non-executive Chair, Ms. Matthews, presides .
  • Attendance: Board met 7 times in 2024; no director attended fewer than 75% of aggregate Board and committee meetings; Ms. Matthews attended the 2024 annual meeting .
  • Committee activity: 2024 meeting counts—Audit (8), Management Development & Compensation (6), Corporate Governance (4) .
  • Time-commitment oversight: Corporate Governance Committee annually reviews each director’s outside positions and time commitments to ensure capacity .
  • Policies: Directors and executives prohibited from hedging or pledging company stock; robust corporate governance documents and independence standards adopted .

Fixed Compensation

ComponentAmountNotes
Annual cash retainer (non-employee director)$100,000Paid annually post election
Chair of the Board cash retainer$212,500Increased $7,500 YoY in 2024
Committee chair feesAudit: $28,000; MD&C: $22,000; Governance: $17,000Annual retainers
Committee member feesAudit: $11,000; MD&C: $7,000; Governance: $7,000Annual retainers
Matching gift programUp to $6,000/yearEligible charitable donations matched
Non-employee director annual comp cap (cash + grant-date equity)$500,000Plan limit; doubled in first year on Board

Performance Compensation

Equity ComponentGrant DateShares/UnitsGrant-Date Fair ValueVesting Terms
Annual RSU grant (non-chair)May 1, 20241,113 RSUs≈$160,000Not disclosed
Annual RSU grant (Chair of the Board)May 1, 20241,304 RSUs≈$187,500Not disclosed
  • 2018 Equity Incentive Plan: Share reserve increased to 4,150,000; prohibits liberal share recycling; non-employee director award cap $500,000 (cash + grant-date equity) annually .
  • 2024 changes: Annual director equity grant increased by $10,000; Chair’s cash retainer increased by $7,500 and equity grant increased by $17,500 based on market peer review .

Other Directorships & Interlocks

External BoardPotential Interlock ConsiderationStatus
Société BIC S.A.Consumer products manufacturer; may overlap with Aptar end-marketsNo related person transactions disclosed since Jan 1, 2024; Audit Committee screens for conflicts
Corewell Health FoundationCharitable/non-profitNo RPT issues disclosed
Former: MillerKnoll, Popeye’sHistorical rolesNo current interlocks

No related person transactions requiring disclosure occurred since Jan 1, 2024; the Audit Committee, composed of disinterested directors, reviews and approves any such transactions under a written policy .

Expertise & Qualifications

  • Executive background: Senior marketing executive in beauty and consumer goods; strategic planning, governance, finance, senior management expertise .
  • Board skills framework: Aptar maintains a Director Skills Matrix emphasizing leadership, public company governance, international experience, industry expertise, financial literacy/risk management, strategy/M&A, digital/cyber, human capital/compensation, sustainability, commercial, manufacturing/supply chain, R&D/innovation .

Equity Ownership

HolderShares Owned% of OutstandingOptions Exercisable/RSUs Vesting ≤60 DaysAs-of Date
Candace Matthews5,070<1%1,304 RSUsMarch 14, 2025
  • Basis of %: Outstanding shares 65,966,138 as of March 14, 2025; Matthews’ beneficial ownership is less than 1% per proxy table .
  • Ownership guidelines: Non-executive directors must hold Aptar stock equal to at least 5× annual cash retainer; current required value $500,000; compliance required within five years; as of record date, each non-employee director is compliant or within phase-in .
  • Hedging/pledging: Prohibited for directors and executives under the Insider Trading Policy .

Insider Trades

YearSection 16 Compliance (Director)Notes
2024In complianceAptar states all directors complied with Section 16(a) in 2024; one late Form 4 related to an executive (Hedi Tlili) due to administrative oversight

Governance Assessment

  • Strengths: Independent, non-executive Chair presiding over executive sessions; active Corporate Governance Committee membership; strong attendance and engagement (Board met 7 times; no director <75% attendance; Matthews attended annual meeting) .
  • Alignment: Robust stock ownership guidelines (5× retainer; $500,000) and annual RSU grants for directors, plus prohibition on hedging/pledging—supports long-term alignment .
  • Compensation discipline: Cash/equity levels positioned near market median; explicit annual cap of $500,000 (cash + grant-date equity) and controlled share recycling under the 2018 Plan .
  • Conflicts oversight: Formal Related Person Transactions Policy with Audit Committee approval; no related person transactions disclosed since Jan 1, 2024 .
  • Watch points: External public board (Société BIC S.A.) in adjacent consumer end-markets—Corporate Governance Committee annually reviews outside commitments/time; no specific conflicts disclosed .

Director Compensation Summary (2024)

ComponentNon-Chair DirectorChair (Matthews)
Annual cash retainer$100,000 $212,500
Committee chair/member feesAudit: $28,000 / $11,000; MD&C: $22,000 / $7,000; Governance: $17,000 / $7,000 Same schedule
Annual RSU grant1,113 RSUs; ≈$160,000 FV (May 1, 2024) 1,304 RSUs; ≈$187,500 FV (May 1, 2024)
Matching giftsUp to $6,000/year Up to $6,000/year
Plan cap (cash + grant-date equity)$500,000/year $500,000/year

Committee Assignments (2024)

CommitteeRoleMeetings Held
Corporate GovernanceMember4

Board leadership: Matthews serves as non-executive Chair, while B. Craig Owens chairs Audit and Matt Trerotola chairs Corporate Governance; committee independence is 100% for Audit, MD&C, and Governance .

Independence & Attendance

AttributeStatus
Independence (NYSE)Independent director; Board is 90% independent (9 of 10)
Board meetings in 20247 total; no director <75% attendance; Matthews attended annual meeting

Related Party & Risk Indicators

  • Related party transactions: None requiring disclosure since Jan 1, 2024; robust Audit Committee review criteria for any RPTs .
  • Hedging/pledging: Prohibited for directors; aligns with investor-friendly governance .
  • Executive sessions: Regular and presided by independent Chair; enhances board effectiveness .
  • Compensation risk: Company and Board concluded policies are not reasonably likely to have a material adverse effect; stock ownership guidelines and committee oversight reduce risk .
  • Section 16(a): Directors compliant in 2024; one administrative late filing for an executive, not a director .

RED FLAGS: None disclosed regarding related-party transactions, hedging/pledging, or attendance; monitor potential interlocks with external boards (e.g., BIC) for transactional ties, though none disclosed and governance processes review outside commitments annually .